Unnamed: 0,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0002699,GO:0002699,positive regulation of immune effector process,6/13,248/18800,7.878474278617e-09,3.00957717443169e-06,1.27714214621791e-06,CD160/CRTAM/KLRD1/MZB1/SEMA7A/TNFSF13,6
GO:0045954,GO:0045954,positive regulation of natural killer cell mediated cytotoxicity,3/13,27/18800,7.48304777371526e-07,8.06268120443027e-05,3.42147397487534e-05,CD160/CRTAM/KLRD1,3
GO:0002702,GO:0002702,positive regulation of production of molecular mediator of immune response,4/13,120/18800,1.07963341789853e-06,8.06268120443027e-05,3.42147397487534e-05,CD160/MZB1/SEMA7A/TNFSF13,4
GO:0002717,GO:0002717,positive regulation of natural killer cell mediated immunity,3/13,32/18800,1.26638971797334e-06,8.06268120443027e-05,3.42147397487534e-05,CD160/CRTAM/KLRD1,3
GO:0002449,GO:0002449,lymphocyte mediated immunity,5/13,365/18800,3.03889781753343e-06,0.0001451073707872,6.1577666302651e-05,CD160/CD8A/CRTAM/KLRD1/TNFSF13,5
GO:0001912,GO:0001912,positive regulation of leukocyte mediated cytotoxicity,3/13,58/18800,7.79679455941294e-06,0.0002291058093612,9.72231872185904e-05,CD160/CRTAM/KLRD1,3
GO:0031343,GO:0031343,positive regulation of cell killing,3/13,65/18800,1.10063863897972e-05,0.0002627774750564,0.0001115120726334,CD160/CRTAM/KLRD1,3
GO:0042267,GO:0042267,natural killer cell mediated cytotoxicity,3/13,72/18800,1.49859847795663e-05,0.0003186090433161,0.0001352047194011,CD160/CRTAM/KLRD1,3
GO:0002836,GO:0002836,positive regulation of response to tumor cell,2/13,15/18800,4.61124801010677e-05,0.0006944916516359,0.0002947140103387,CD160/CRTAM,2
GO:0002839,GO:0002839,positive regulation of immune response to tumor cell,2/13,15/18800,4.61124801010677e-05,0.0006944916516359,0.0002947140103387,CD160/CRTAM,2
GO:0002440,GO:0002440,production of molecular mediator of immune response,4/13,312/18800,4.72690652945945e-05,0.0006944916516359,0.0002947140103387,CD160/MZB1/SEMA7A/TNFSF13,4
GO:0001909,GO:0001909,leukocyte mediated cytotoxicity,3/13,131/18800,8.98585135921892e-05,0.001207832817726,0.0005125551224298,CD160/CRTAM/KLRD1,3
GO:0002460,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,4/13,370/18800,9.16941144346992e-05,0.001207832817726,0.0005125551224298,CD8A/KLRD1/LY9/TNFSF13,4
GO:0002418,GO:0002418,immune response to tumor cell,2/13,27/18800,0.0001534274812021,0.0018125739054652,0.0007691826438182,CD160/CRTAM,2
GO:0046631,GO:0046631,alpha-beta T cell activation,3/13,158/18800,0.0001565836096344,0.0018125739054652,0.0007691826438182,CD160/CRTAM/LY9,3
GO:0001819,GO:0001819,positive regulation of cytokine production,4/13,475/18800,0.0002399925244686,0.0026193469813438,0.0011115443238549,CD160/CRTAM/LY9/SEMA7A,4
GO:0001906,GO:0001906,cell killing,3/13,185/18800,0.0002493525215421,0.00264590731192,0.00112281544788,CD160/CRTAM/KLRD1,3
GO:0002819,GO:0002819,regulation of adaptive immune response,3/13,188/18800,0.0002614352168707,0.0026991419687731,0.0011454060710693,CD160/KLRD1/TNFSF13,3
GO:0002347,GO:0002347,response to tumor cell,2/13,42/18800,0.0003741606189127,0.0037612988532808,0.0015961422524256,CD160/CRTAM,2
GO:1900280,GO:1900280,"negative regulation of CD4-positive, alpha-beta T cell costimulation",1/13,1/18800,0.0006914893617021,0.0063462889200526,0.002693106899113,CD160,1
GO:0030217,GO:0030217,T cell differentiation,3/13,263/18800,0.0006977595147701,0.0063462889200526,0.002693106899113,CD8A/CRTAM/LY9,3
GO:0031349,GO:0031349,positive regulation of defense response,3/13,289/18800,0.0009171815871251,0.0079628037791323,0.0033790900578296,CD160/CRTAM/KLRD1,3
GO:0002757,GO:0002757,immune response-activating signal transduction,3/13,300/18800,0.0010218256852181,0.0083050513139008,0.0035243259915699,CD160/CD8A/KLRD1,3
GO:1903489,GO:1903489,positive regulation of lactation,1/13,2/18800,0.0013825373237371,0.0099647029748603,0.0042286146545287,PRL,1
GO:0002355,GO:0002355,detection of tumor cell,1/13,3/18800,0.0020731441443984,0.0125790694508986,0.0053380454545009,CRTAM,1
GO:0090716,GO:0090716,adaptive immune memory response,1/13,3/18800,0.0020731441443984,0.0125790694508986,0.0053380454545009,CD160,1
GO:0002367,GO:0002367,cytokine production involved in immune response,2/13,100/18800,0.0021029931386302,0.0125790694508986,0.0053380454545009,CD160/SEMA7A,2
GO:0046634,GO:0046634,regulation of alpha-beta T cell activation,2/13,105/18800,0.0023151482729497,0.0133997975798002,0.0056863290914555,CD160/CRTAM,2
GO:0002456,GO:0002456,T cell mediated immunity,2/13,112/18800,0.0026285252875434,0.0149865173110687,0.0063596684097673,CD8A/KLRD1,2
GO:0002683,GO:0002683,negative regulation of immune system process,3/13,425/18800,0.0027712819630729,0.0151949574212622,0.0064481219147819,CD160/CRTAM/KLRD1,3
GO:0032102,GO:0032102,negative regulation of response to external stimulus,3/13,429/18800,0.0028458815510071,0.0151949574212622,0.0064481219147819,KLRD1/SEMA7A/TSPAN8,3
GO:0032609,GO:0032609,interferon-gamma production,2/13,117/18800,0.0028639710322797,0.0151949574212622,0.0064481219147819,CD160/CRTAM,2
GO:0032103,GO:0032103,positive regulation of response to external stimulus,3/13,442/18800,0.0030969464859945,0.015986939968242,0.0067842070959197,CD160/CRTAM/KLRD1,3
GO:0048298,GO:0048298,positive regulation of isotype switching to IgA isotypes,1/13,5/18800,0.0034530353940859,0.0171306431239068,0.0072695481980756,TNFSF13,1
GO:0016525,GO:0016525,negative regulation of angiogenesis,2/13,149/18800,0.0045957551694698,0.0216738083300922,0.0091974827303229,CD160/PRL,2
GO:0048290,GO:0048290,isotype switching to IgA isotypes,1/13,7/18800,0.0048311651743624,0.0219702987691244,0.0093233012136819,TNFSF13,1
GO:0097021,GO:0097021,lymphocyte migration into lymphoid organs,1/13,8/18800,0.0055195701577464,0.024235354025967,0.0102844985395396,CRTAM,1
GO:0001915,GO:0001915,negative regulation of T cell mediated cytotoxicity,1/13,10/18800,0.0068950615983537,0.0283216508663562,0.0120185567192584,KLRD1,1
GO:0050864,GO:0050864,regulation of B cell activation,2/13,200/18800,0.0081313781967543,0.0329029202774805,0.0139626611262937,MZB1/TNFSF13,2
GO:0002285,GO:0002285,lymphocyte activation involved in immune response,2/13,201/18800,0.0082099028155795,0.0329029202774805,0.0139626611262937,LY9/TNFSF13,2
GO:0001768,GO:0001768,establishment of T cell polarity,1/13,13/18800,0.0089550063018017,0.0349062490539621,0.0148127923789203,CRTAM,1
GO:0072540,GO:0072540,T-helper 17 cell lineage commitment,1/13,13/18800,0.0089550063018017,0.0349062490539621,0.0148127923789203,LY9,1
GO:0046007,GO:0046007,negative regulation of activated T cell proliferation,1/13,15/18800,0.0103261107965489,0.0390551913295215,0.0165734347333875,CRTAM,1
GO:0050670,GO:0050670,regulation of lymphocyte proliferation,2/13,230/18800,0.0106358313754214,0.0398322312295193,0.0169031788628988,CRTAM/MZB1,2
GO:0032944,GO:0032944,regulation of mononuclear cell proliferation,2/13,233/18800,0.0109029702534752,0.0404362586099758,0.0171595035159446,CRTAM/MZB1,2
